Full Name | Photrexa® (riboflavin 5’-phosphate ophthalmic solution) |
Drug | Photrexa |
Manufacturer | Glaukos |
Route of Administration | Intraocular |
Site of Care | Healthcare Facility |
Approved Indication | The treatment of progressive keratoconus (1.1) and corneal ectasia following refractive surgery |
Disease | Progressive Keratoconus; Corneal Ectasia |
Therapeutic Area | Ophthalmology |
Enrollment Form Link | Photrexa Enrollment Form |
Phone Number | 800-550-7207 |
Fax Number | 877-277-3139 |
Product Website |
About Corneal Ectasia
Corneal ectasia is a condition characterized by progressive thinning and bulging of the cornea, the transparent front part of the eye. Commonly associated with conditions like keratoconus, post-LASIK surgery complications, or corneal degeneration, corneal ectasia results in an altered corneal shape, impacting vision. Symptoms include blurred or distorted vision, sensitivity to light, and difficulty with night vision.